+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Bullous Keratopathy - Market Insights, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Bullous Keratopathy - Market Insights, Epidemiology, and Market Forecast - 2034

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Potassium Channel Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Potassium Channel Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Dopamine D2 Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Dopamine D2 Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Stomatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Stomatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Platelet-derived Growth Factor Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Platelet-derived Growth Factor Receptor Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cannabis Use Disorder (CUD) - Pipeline Insight, 2025 - Product Thumbnail Image

Cannabis Use Disorder (CUD) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Epstein-Barr Virus-associated Post-Transplant Lymphoproliferative Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Epstein-Barr Virus-associated Post-Transplant Lymphoproliferative Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Liver Fibrosis- Pipeline Insight, 2025 - Product Thumbnail Image

Liver Fibrosis- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 85 Pages
  • Global
From
Post-transplant Lymphoproliferative Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Post-transplant Lymphoproliferative Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Central Precocious Puberty - Pipeline Insight, 2025 - Product Thumbnail Image

Central Precocious Puberty - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Cocaine Use Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Cocaine Use Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Egg Allergy - Pipeline Insight, 2025 - Product Thumbnail Image

Egg Allergy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Serotonin Receptor 2 Angonist - Pipeline Insight, 2025 - Product Thumbnail Image

Serotonin Receptor 2 Angonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Leptomeningeal Disease -Pipeline Insight, 2025 - Product Thumbnail Image

Leptomeningeal Disease -Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
PD-1 And PD-L1 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

PD-1 And PD-L1 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 200 Pages
  • Global
From
Sodium-glucose Transporter 2 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Sodium-glucose Transporter 2 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Bronchitis - Pipeline Insight, 2025 - Product Thumbnail Image

Bronchitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Alopecia Areata- Pipeline Insight, 2025 - Product Thumbnail Image

Alopecia Areata- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Schizophrenia- Pipeline Insight, 2025 - Product Thumbnail Image

Schizophrenia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more